Faruk Abdullah, General Manager, Advisory Services shares insights on the once-in-a-lifetime moment of market macro dynamics, making in-licensing opportunities.
The opportunity at hand for large pharma has been created by the once-in-a-lifetime, current market dynamics. These macroeconomic factors include:
- A decade-long trend of funding being funneled into small and mid-sized pharma = the number of companies with small assets coming to market has increased
- Public markets have contracted over the last 18 months and companies are now hitting an evaluation shortfall. These two conditions have created an environment where many companies can no longer afford to commercialize their products.